Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.0090 USD
Change Today -0.001 / -10.00%
Volume 1.0K
NGSX On Other Exchanges
Symbol
Exchange
OTC US
Berlin
As of 8:10 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ronald A. Martell

Former Chief Executive Officer, President and Director, NeurogesX, Inc.
AgeTotal Calculated CompensationThis person is connected to 46 board members in 4 different organizations across 7 different industries.

See Board Relationships
52--

Background*

Mr. Ronald A. Martell, also known as Ron, served as the Chief Executive Officer of Sevion Therapeutics, Inc. (alternate name Senesco Technologies Inc) from June 2014 to January 8, 2015. Mr. Martell served as the Chief Executive Officer and President of NeurogesX, Inc. from January 1, 2012 to July 8, 2013. Mr. Martell served as the Chief Executive Officer of Poniard Pharmaceuticals, Inc. from February 5, 2010 to December 2011. For more than 25 years, Mr. Martell has led ...

Read Full Background

Corporate Headquarters*

2215 Bridgepointe Parkway
San Mateo, California 94404

United States

Phone: --
Fax: --

Board Members Memberships*

Director
2005-Present
Director
2006-Present
Chairman of The Board
2012-2013
Former Chief Executive Officer, President and Director
2014-2015
Former Chief Executive Officer and Director
2015-Present
Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NGSX:US $0.01 USD -0.001

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Daniel N. Swisher Jr.Chief Executive Officer, President and Director
Sunesis Pharmaceuticals, Inc.
$488.1K
John R. Plachetka Pharm D.Co-Founder, Chairman, Chief Executive Officer and President
POZEN Inc.
$609.6K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEUROGESX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.